Hexagon Bio: This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi Portfolio News / By Karina Tin September 15, 2020 Hexagon Bio: This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi Read More »
Hexagon Bio Closes $47 Million in Series A Financing to Advance Novel Oncology and Infectious Disease Therapies Portfolio News / By Karina Tin September 15, 2020 Hexagon Bio Closes $47 Million in Series A Financing to Advance Novel Oncology and Infectious Disease Therapies Read More »
Escient Pharmaceuticals Raises $77.5 Million Series B Round And Initiates A Phase 1/1b Clinical Trial Of EP547, A MRGPR-Targeted Therapy To Treat Cholestatic And Uremic Pruritus Portfolio News / By Karina Tin September 14, 2020 Escient Pharmaceuticals Raises $77.5 Million Series B Round And Initiates A Phase 1/1b Clinical Trial Of EP547, A MRGPR-Targeted Therapy To Treat Cholestatic And Uremic Pruritus Read More »
Casma Therapeutics Announces $50 Million Series B Financing Portfolio News / By Karina Tin September 10, 2020 Casma Therapeutics Announces $50 Million Series B Financing Read More »
NGM Bio Presents Comprehensive Findings from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Oral Plenary Presentation at The Digital International Liver Congress™ (ILC) 2020 and Announces Enrollment Completed in Phase 2b ALPINE 2/3 Study Portfolio News / By Karina Tin August 29, 2020 NGM Bio Presents Comprehensive Findings from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Oral Plenary Presentation at The Digital International Liver Congress™ (ILC) 2020 and Announces Enrollment Completed in Phase 2b ALPINE 2/3 Study Read More »
RAPT Therapeutics Reports Second Quarter 2020 Financial Results Portfolio News / By Karina Tin August 13, 2020 RAPT Therapeutics Reports Second Quarter 2020 Financial Results Read More »
NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results Portfolio News / By Karina Tin August 12, 2020 NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results Read More »
Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress Portfolio News / By Karina Tin August 10, 2020 Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress Read More »
Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates Portfolio News / By Karina Tin August 6, 2020 Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates Read More »
Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update Portfolio News / By Karina Tin August 5, 2020 Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update Read More »
